Standout Papers

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without ... 2019 2026 2021 2023 333
  1. Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer (2019)
    Jeffrey D. Bradley, Chen Hu et al. Journal of Clinical Oncology

Immediate Impact

62 standout
Sub-graph 1 of 21

Citing Papers

Traditional Chinese medicine in lung cancer treatment
2025 Standout
Radiotherapy toxicities: mechanisms, management, and future directions
2025 Standout
1 intermediate paper

Works of Joanne Meng being referenced

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer
2019 Standout

Author Peers

Author Last Decade Papers Cites
Joanne Meng 157 367 170 169 7 485
Julieta Corral 286 199 238 156 18 536
Joseph M. Colasanto 173 375 98 165 12 550
Theodore J. Robnett 176 395 142 136 9 504
N. Coliarakis 171 426 85 269 8 544
M Riggi 103 313 49 153 16 444
Steve Kelly 140 248 75 229 12 485
Lawrence R. Coia 118 201 78 128 8 426
Ronald Shapiro 157 321 226 67 17 445
Wei Yin 71 404 97 107 12 501
John M. Schallenkamp 230 327 314 125 10 538

All Works

Loading papers...

Rankless by CCL
2026